BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6256922)

  • 1. Effects of neutral proteases from human leukocytes on structure and biological properties of human factor VIII.
    Kopeć M; Bykowska K; Lopaciuk S; Jelenska M; Kaczanowska J; Sopata I; Wojtecka E
    Thromb Haemost; 1980 Jul; 43(3):211-7. PubMed ID: 6256922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of human Factor VIII by granulocyte proteases.
    Váradi K; Marossy K; Asbóth G; Elödi P; Elödi S
    Thromb Haemost; 1980 Feb; 43(1):45-8. PubMed ID: 6773173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neutral proteases from blood leukocytes on human platelets.
    Bykowska K; Kaczanowska J; Karpowicz M; Stachurska J; Kopeć M
    Thromb Haemost; 1983 Dec; 50(4):768-72. PubMed ID: 6320486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes.
    Solomon A; Gramse M; Havemann K
    Eur J Immunol; 1978 Nov; 8(11):782-5. PubMed ID: 102513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
    Vermylen J; Bottecchia D
    Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution to the isolation and study of the molecular weight of human factor VIII].
    Mazurier C; Parquet-Gernez A; Goudemand M; Montreuil J
    Pathol Biol (Paris); 1975 Dec; 23 suppl():11-6. PubMed ID: 57588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural model of factor VIII complex].
    Furlan M; Beck EA
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1378. PubMed ID: 1006260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of blood platelet function induced by neutral proteases from human leukocytes.
    Bykowska K; Kaczanowska J; Karpowicz M; Lopaciuk S; Kopeć M
    Thromb Res; 1985 Jun; 38(5):535-46. PubMed ID: 3892761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihaemophilic factor (factor VIII) from human granulocytes.
    Szmitkowski M; Prokopowicz J; Szmitkowska K
    Haematologia (Budap); 1977; 11(1-2):177-87. PubMed ID: 27427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor).
    Beck EA; Bachmann P; Barbier P; Furlan M
    Thromb Haemost; 1976 Feb; 35(1):186-90. PubMed ID: 1085500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.
    Over J; Sixma JJ; Bruïne MH; Trieschnigg MC; Vlooswijk RA; Beeser-Visser NH; Bouma BN
    J Clin Invest; 1978 Aug; 62(2):223-34. PubMed ID: 670391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte elastase-like proteinase purified by affinity chromatography with Suc-L-Tyr-D-Leu-D-Val-pNA, and its identification with human spleen fibrinolytic proteinase.
    Nagamatsu Y; Okamoto U; Tsuda Y; Okada Y
    Thromb Haemost; 1984 Apr; 51(2):243-7. PubMed ID: 6377566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
    Over J; Bouma BN; Sixma JJ; Bolhuis PA; Vlooswijk RA
    J Lab Clin Med; 1980 Mar; 95(3):323-34. PubMed ID: 7354239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of factor VIII related protein synthesized by human endothelial cell: a study of structure and function.
    Chan V; Chan TK
    Thromb Haemost; 1982 Oct; 48(2):177-81. PubMed ID: 6817445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin.
    Ohlsson K; Collen D
    Scand J Clin Lab Invest; 1977 Jun; 37(4):345-50. PubMed ID: 210494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neutral proteases from human leukocytes on plasma fibronectin.
    Wojtecka-Lukasik E; Kaczanowska J; Tomczak Z; Sopata I; Kopeć M
    Thromb Res; 1984 Mar; 33(5):471-6. PubMed ID: 6372156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.